Earnings roundup: Thermo Fisher revenue dips, but EPS jumps 15 percent

MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.

Here’s a quick rundown of a few releases over the past couple days:

Thermo Fisher revenue dips, but EPS jumps 15 percent
Thermo Fisher Scientific Inc. (NYSE:TMO) posted net income of $297.5 million, or 75 cents per diluted share, on revenue of $2.78 billion during the three months ended Dec. 31. That compares with net income of $273.3 million, or 65 cents per diluted share, on revenue of $2.84 billion during the same period last year.
Read more

Allergan profits, sales rise
Allergan Inc. (NYSE:AGN) reported net income of $263.1 million, or 85 cents per diluted share, on revenue of $1.31 billion during the three months ended Dec. 31. That compares with a profit of $221.5 million, or 72 cents per diluted share, on revenue of $1.22 billion during the same period last year.
Read more

Cardiovascular Systems’ increased sales temper losses
Cardiovascular Systems Inc. (NSDQ:CSII) reported a loss of $2.0 million, or 13 cents per diluted share, on sales of $18.8 million during the three months ended Dec. 31. That compares with a loss of $6.8 million, or 46 cents per diluted share, on sales of $15.1 million during the same period last year.
Read more

MKS Instruments profits rocket over 100 percent
MKS Instruments Inc. (NSDQ:MKSI) reported net income of $35.9 million or 70 cents per diluted share, on sales of $219.0 million during the three months ended Dec. 31. That compares with net income of $14.9 million, or 30 cents per diluted share, on sales of $142.8 million during the same period last year.
Read more

Hospira profits sink 37 percent after sales drop
Hospira Inc. (NYSE:HSP) recorded a profit of $60.6 million, or 36 cents per diluted share, on sales of $992.1 million during the three months ended Dec. 31. That compares with a profit of $96.7 million, or 58 cents per diluted share, on sales of $1.06 billion during the same period last year.
Read more

Affymetrix sales fall, but income rises
Affymetrix Inc. (NSDQ:AFFX) posted net income of approximately $4.0 million, or 6 cents per diluted share, on sales of $84.9 million during the three months ended Dec. 31. That compares with net income of $2.8 million, or 4 cents per diluted share, on sales of $88.9 million during the same period last year.
Read more